Fang, J., M. Genco, and R. Caskey. “COVID-19 Precipitating Euglycaemic Diabetic Ketoacidosis With SGLT2 Inhibitor Use”. European Journal of Case Reports in Internal Medicine, vol. 7, no. 11, Oct. 2020, doi:10.12890/2020_001943.